We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$349B
AUM Growth
+$31.1B
Cap. Flow
+$7.21B
Cap. Flow %
2.07%
Top 10 Hldgs %
18.28%
Holding
8,254
New
342
Increased
3,908
Reduced
2,518
Closed
710

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Technology 11.68%
3 Healthcare 9.18%
4 Industrials 8.18%
5 Energy 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STCN
7851
DELISTED
Steel Connect, Inc. Common Stock
STCN
-14
Closed
BSFC
7852
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
0
ONCR
7853
DELISTED
Oncorus, Inc.
ONCR
$0 ﹤0.01%
228
+3
+1% +$2
HCNE
7854
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
-82,109
Closed -$801K
ZTAQU
7855
DELISTED
Zimmer Energy Transition Acquisition Corp. Units
ZTAQU
-12,745
Closed -$125K
FNCH
7856
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-5
Closed
KSPN
7857
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
-1
Closed
ACOR
7858
DELISTED
Acorda Therapeutics
ACOR
$0 ﹤0.01%
16
-1
-6% -$12
BLCM
7859
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
5
TCRR
7860
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$0 ﹤0.01%
85
QTEK
7861
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
-124
Closed
LABP
7862
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$0 ﹤0.01%
38
-31
-45% -$119
SGTX
7863
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-1,400
Closed -$9K
SEAC
7864
DELISTED
Seachange International Inc
SEAC
-29
Closed
APTX
7865
DELISTED
Aptinyx Inc. Common Stock
APTX
-432
Closed
FOXO.WS
7866
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$0 ﹤0.01%
1,000
LVAC
7867
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
-2,062
Closed -$21K
BNNR
7868
DELISTED
Banner Acquisition Corp. Class A Common Stock
BNNR
-63,923
Closed -$633K
VYNT
7869
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$0 ﹤0.01%
+3
New +$5
OIG
7870
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$0 ﹤0.01%
43
-39
-48% -$447
CIH
7871
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$0 ﹤0.01%
161
PLXP
7872
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-245
Closed
KVSC
7873
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
-224,710
Closed -$2.2M
AGRX
7874
DELISTED
Agile Therapeutics
AGRX
$0 ﹤0.01%
+1
New +$12
CDAK
7875
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-148
Closed

Similar funds

Royal Bank of Canada's Q4 2022 Portfolio in Review

As of Q4 2022, Royal Bank of Canada held 8,254 positions worth $349B, up 9.8% from $318B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Royal Bank of Canada's Q4 2022 filing shows 342 new, 3,908 increased, 2,518 reduced and 710 closed positions. Its largest new stake was Brookfield Asset Management: 22,158,258 shares worth $635M. The largest sale was Enbridge, an estimated $955M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Royal Bank of Canada's largest Q4 2022 buy was Brookfield Asset Management: 22,158,258 shares worth $635M.
  • Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $673M increase.
  • Royal Bank of Canada's biggest Q4 2022 reduction was Enbridge, cutting an estimated $955M.
  • Royal Bank of Canada fully exited Switch, Inc. Class A Common Stock in Q4 2022, selling an estimated $396M.
  • Royal Bank of Canada's ten largest holdings make up 18% of its $349B portfolio in Q4 2022.
  • Royal Bank of Canada opened 342 new positions and closed 710 in Q4 2022.
  • Royal Bank of Canada's portfolio value rose 9.8% quarter-over-quarter to $349B.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.